A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma
Goar Egoryan, Alex Zimmet, Mingwei Yu, Joseph Pozdol, Aruna Subramanian, Sunil Reddy, Joanna Nelson · 2024
Read A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma by Goar Egoryan, Alex Zimmet, Mingwei Yu, Joseph Pozdol, Aruna Subramanian, Sunil Reddy, Joanna Nelson (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11646813.txt.
Description
Goar Egoryan and six colleagues report severe stomach infection by a common virus in a cancer patient on immune therapy, in a twenty twenty-four case paper. The sixty-three-year-old man had advanced skin cancer treated with an immune checkpoint drug for a year plus one shot of an oncolytic virus. He arrived with worsening indigestion, heavy weight loss, and a need for vein feeding.
Scans and biopsies showed the virus, cytomegalovirus, had ulcerated his stomach. Such flare-ups are rare without prior immune-suppressing care. Six weeks of antiviral therapy cleared the infection, and he resumed cancer care on a protective oral drug. The authors flag this risk in patients on immune therapy.
Catalog record
| CREATOR | Goar Egoryan, Alex Zimmet, Mingwei Yu, Joseph Pozdol, Aruna Subramanian, Sunil Reddy, Joanna Nelson |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 17 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |